1-4 of 4
Fang Xiao, PhD
Close
Sort by
Journal Articles

High Expression of NEK2 Induces Drug Resistance by Inhibiting Premature Senescence Through Activation of the PI3K/Akt Pathway in Myeloma and Other Cancers,

Fenghuang Zhan, MD, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3923.
https://doi.org/10.1182/blood.V118.21.3923.3923
Published: 2011
Journal Articles

Inhibition of RARĪ±2 or Its Downstream Signaling Pathways Decreases Drug Resistance in Myeloma

Guido J. Tricot, MD, PhD, Ye Yang, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 989.
https://doi.org/10.1182/blood.V118.21.989.989
Published: 2011
Journal Articles

Targeting NEK2 Kinase In Drug-Resistant Multiple Myeloma with Small Molecule Inhibitors

Fenghuang Zhan, MD, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MS, Benjamin Mughal, BS, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 788.
https://doi.org/10.1182/blood.V116.21.788.788
Published: 2010
Journal Articles

PTH- PTHR1 Axis Control on Anti-Myeloma Effect of Proteasome Inhibitors

Maurizio Zangari, MD, Fang Xiao, PhD, Ye Yang, PhD, Hongwei Xu, MS, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 5017.
https://doi.org/10.1182/blood.V116.21.5017.5017
Published: 2010